Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp300 | Muscle, physical activity and bone | ECTS2013

Vitamin D deficiency is associated with nonspecific skeletal pain in Saudi women

Hussein Khulood , Alkadi Hanan , Lanham-New Suzan , Ardawi Mohamad

Introduction and aims: Deficiency of vitamin D has been reported in subjects with many types of musculoskeletal pain. The aim of the present study was to determine the association between serum 25-hydroxyvitamin D (25(OH)D) and nonspecific skeletal pain in healthy Saudi women.Methods: Serum 25(OH)D were measured for 223 healthy women with nonspecific skeletal pain at different regions of the skeletal system including back pain. Serum 25(OH)D was measured...

ba0001pp395 | Osteoporosis: treatment | ECTS2013

Renal function and safety result after 1 year treatment of zoledronic acid in Chinese women with postmenopausal osteoporosis

Shen Huiyong , Sun Yue , Liu Xun

Objective: Zoledronic acid (Zol) has been demonstrated to be an effective therapy to treat postmenopausal osteoporosis (PMO) in Chinese women in a 12-month post-marketing observational study (ZOOM study). As an I.V. bisphosphonates, Zol are exclusively excreted via the kidneys. We present a report of the renal function and safety data of once-yearly Zol 5 mg treatment.Subjects and methods: A total of 373 PMO patients from 30 different centers in China wi...

ba0001pp461 | Other diseases of bone and mineral metabolism | ECTS2013

QTc interval in hypercalcemic kidney transplant recipients

Smalcelj Ruzica , Smalcelj Anton

Bone metabolism disorders and hypercalcemia occur often in kidney transplant recipients.In 59 kidney recipients (aged 22–74 years, creatinine clearance > 50 ml/min) who were hypercalcemic on more than three consecutive previous visits, the following serum parameters were estimated 1–147 months posttransplant: iPTH, Ca total and ionized, Pi, total and bone alkaline phosphatase, crosslaps, 25(OH)D3, cyclosporine/tacrolimus trough levels. Urin...

ba0001pp470 | Other diseases of bone and mineral metabolism | ECTS2013

Determinants of bone loss in cystic fibrosis

Gensburger Deborah , Chapurlat Roland , Nove-Josserand Raphaele , Rabilloud Muriel , Durieu Isabelle

Objectives: Bone disease is now well described in cystic fibrosis adult patients. CF bone disease is multifactorial but many studies suggested the crucial role of inflammation and chronic pulmonary infection. The objectives of this study were to assess the prevalence of osteoporosis in a current adult CF population and to examine its relationship with infections and inflammation.Methods: Patients were recruited in the adult CF Lyon Centre and assessed in...

ba0001pp488 | Other diseases of bone and mineral metabolism | ECTS2013

Circulating RANKL is not a reliable biomarker for bone loss in primary hyperparathyroidism

Grigorie Daniel , Sucaliuc Alina , Neacsu Elena , Militaru Roxana , Diaconescu Alina , Ivan Mirela

Introduction: The aim was to examine serum levels of RANKL, OPG and TNF-α before and after curative surgery (PTX) in patients with primary hyperparathyroidism, and their relationship to bone turnover and bone loss.Patients and methods: A 46 patients with rather severe primary hyperparathyroidism (mean PTH=196 pg/ml, mean total Ca=11.4 mg/dl, spine osteoporosis in 50%, hip osteoporosis in a third) mean age of 63.3±12.3 years, 41 women/five males...

ba0002op15 | (1) | ICCBH2013

Dissecting the role of osteoblast derived nitric oxide in bone remodeling

Grover Monica , Nagamani Sandesh , Erez Ayelet , Lee Brendan

Background: Bone accrual during adolescence is the main contributor to peak bone mass. Bone remodeling is a balance between bone formation and resorption as directed by osteoblast and osteoclast activity, respectively. nitric oxide (NO) is a potent regulator of bone remodeling via mediating effects of cytokines, estrogen and mechanical strain. NO is synthesized from the conversion of L-arginine to L-citrulline by the enzyme nitric oxide synthase (...

ba0003pp26 | Bone biomechanics and quality | ECTS2014

Structural analysis of tooth and jawbone in a type 2 diabetes mouse model

Pabisch Silvia , Yamaguchi Tsuguno , Koike Yasushi , Egashira Kenji , Kataoka Shinsuke , Wagermaier Wolfgang , Weinkamer Richard , Murakoshi Michiaki , Fratzl Peter

In type 2 diabetes mellitus (T2DM) patients, an increased fracture risk is observed, although the bone mineral density is even higher than in non-diabetic patients, which raises the question of the quality of the organic and inorganic matrix in bone1,2. T2DM is also known to favor inflammation of the gingiva and paradontosis in general. However, little is known about the mineral nano-architecture in the mandible and about the possible influence of diabetes. Using sy...

ba0003pp164 | Cell biology: osteoclasts and bone resorption | ECTS2014

Novel highly sensitive ELISA to measure free, bioactive, human soluble RANKL

Suciu Andreea , Breitwieser Andreas

RANKL, the receptor activator of nuclear factor kappa B ligand, is an essential factor for the formation of mature osteoclasts. Together with its receptor RANK and its antagonist Osteoprotegerin (OPG) RANKL is a key regulator in bone metabolism1. RANKL is a membrane-bound protein that can be segregated to a soluble form (sRANKL), whereas only the latter has been reported to be bioactive2. Due to its low circulating levels and the nature of the analyte bin...

ba0003pp347 | Osteoporosis: treatment | ECTS2014

The efficacy of the treatment with intravenous ibandronate in common population.

Flanderova Marie

Objectives: To confirm effect of intravenous treatment with ibandronate every three months in common population of postmenopausal women.Methods: Patients with postmenopausal osteoporosis, who fulfil ACR criteria for postmenopausal osteoporosis and were treated with intravenous ibandronate for two years, underwent DEXA examination.Results: A 50 women suffering from postmenopausal osteoporosis were treated with ibandronate i.v. every...

ba0003pp391 | Other diseases of bone and mineral metabolism | ECTS2014

Excess dietary calcium intake associated with higher Framingham risk score in 25-hydroxyvitamin D deficient male; analysis of the Korea National Health and Nutrition Examination Survey (KNHANES 2008–2011)

Choi Sung-Jin , Joo Nam-Seok , Kim Se-Il , Song Go-Eun , Kim Jin-Ho

Background and objectives: The association between excess calcium intake and cardiovascular mortality has been reported, but the association has not yet been explored according to serum vitamin D status. Thus, we investigated the relation of dietary calcium intake and Framingham risk score (FRS) according to serum 25-hydroxyvitamin D (25(OH)D) status.Methods: A total of 7809 subjects (3452 males and 4357 female) aged over 40 years from the data of the Ko...